Welcome to the investors section of Adocia
Adocia is a biotechnology company specialized in the development of best-in-class medicines from already approved therapeutic proteins.
Latest Press Releases
- 2018/10/05Adocia to hold an ordinary shareholders’ meeting on November 9, 2018 in Lyon
- 2018/10/04Number of shares and voting rights of ADOCIA as of September 30, 2018
- 25-26 October 2018 The 13th Annual Peptide Therapeutics Symposium, La Jolla, CA, USA - The Symposium continues the tradition of excellence in presenting ‘best of the best’ advances in the field of peptide therapeutics. At this occasion, Adocia will present a Poster dedicated to its BioChaperone® Technology